CoverageForm 410-K10-Q8-K13D13G13F

Stelzer Laurie

CIK 0001644348
EVP & Chief Financial OfficerDirector

Filings

17

Latest May 29, 2026

Issuers covered

7

Showing

17 of 17

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Stelzer Laurie. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Stelzer Laurie has filed

TickerIssuerFilingsLast filed
MRTXMirati Therapeutics, Inc.4Aug 10, 2023
PMVPPmv Pharmaceuticals, Inc.4Jun 9, 2025
SYRESpyre Therapeutics, Inc.4May 29, 2026
ARNAArena Pharmaceuticals Inc2Mar 11, 2022
MBXMbx Biosciences, Inc.1Jan 22, 2026
SIONSionna Therapeutics, Inc.1Jun 16, 2025
SURFSurface Oncology, Inc.1Jun 10, 2022

All filings

17 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue